Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RCM monitoring of topical ivermectin in rosacea
NL-OMON45450Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ivermectin in rosacea, sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in Demodex density from baseline to week 16. Started Feb 2018; status: active, not recruiting.
02
Drugs
ivermectin
03
Conditions
rosacea
Beyond the preview
Go deeper on NL-OMON45450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45450.